List of insiders holdings for SAB Biotherapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Hamilton Edward D. 10% Owner |
2021-10-26 21:51:00 | 2,668,049 7,299,915 |
9,967,964 | Form 4 |
2 | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director |
2023-11-28 16:05:50 | 4,612,951 0 |
4,612,951 | Form 4 |
3 | Moin Andrew Director |
2023-11-28 16:05:14 | 0 4,612,951 |
4,612,951 | Form 4 |
4 | Katz Ilan Director 10% Owner |
2021-10-15 10:51:05 | 1,500 3,047,825 |
3,049,325 | Form 4 |
5 | Big Cypress Holdings LLC CEO and CFO 10% Owner |
2022-05-27 16:24:59 | 965,299 0 |
965,299 | Form 13D |
6 | Randall Charles Hiram Chief Strategy Officer |
2021-10-26 21:46:48 | 506,276 0 |
506,276 | Form 4 |
7 | Beyer Russell P Chief Financial Officer |
2023-03-16 16:27:20 | 275,000 0 |
275,000 | Form 4 |
8 | Bausch Christoph Lawrence CHIEF OPERATING OFFICER |
2024-02-23 16:50:07 | 140,000 0 |
140,000 | Form 4 |
9 | To Lucy See Remarks |
2024-08-13 17:00:06 | 125,000 0 |
125,000 | Form 4 |
10 | Wu Hua SVP Research & Product Dev. |
2021-10-26 21:52:27 | 111,871 4,653 |
116,524 | Form 4 |
11 | King Michael CHIEF FINANCIAL OFFICER |
2024-02-23 16:45:19 | 115,000 0 |
115,000 | Form 4 |
12 | Turner Mervyn Director |
2021-10-26 21:49:46 | 79,192 0 |
79,192 | Form 4 |
13 | HAMILTON CHRISTINE E Director |
2024-07-17 16:30:08 | 30,262 46,528 |
76,790 | Form 4 |
14 | SKYLER JAY S Director |
2024-07-17 16:30:12 | 55,000 0 |
55,000 | Form 4 |
15 | Ellias Helen K. Director |
2024-11-05 16:41:10 | 55,000 0 |
55,000 | Form 4 |
16 | Sullivan Eddie Joe PRESIDENT |
2024-07-17 16:30:11 | 50,975 0 |
50,975 | Form 4 |
17 | Kropotova Alexandra CHIEF MEDICAL OFFICER |
2025-04-01 16:19:49 | 47,249 0 |
47,249 | Form 4 |
18 | Reich Samuel J CEO & EXECUTIVE CHAIRMAN |
2024-07-17 16:30:05 | 35,700 0 |
35,700 | Form 4 |
19 | Polvino William James Director |
2024-07-17 16:30:13 | 33,958 0 |
33,958 | Form 4 |
20 | Link David Charles Director |
2024-07-17 16:30:07 | 29,305 0 |
29,305 | Form 4 |
21 | Conley Mark William See Remarks |
2024-06-24 17:00:12 | 25,000 0 |
25,000 | Form 3 |
22 | Finnegan Frederick Chief Business Officer |
2022-03-18 21:15:43 | 23,453 0 |
23,453 | Form 4 |
23 | Luke Thomas Charles Chief Medical Officer |
2022-03-18 21:15:47 | 20,519 0 |
20,519 | Form 4 |
24 | Giberson Scott Director |
2024-07-17 16:30:03 | 20,000 0 |
20,000 | Form 4 |
25 | Lucera Erick Director |
2024-07-17 16:30:09 | 20,000 0 |
20,000 | Form 4 |
26 | Spragens Jeffrey G Director |
2024-07-17 16:30:14 | 20,000 0 |
20,000 | Form 4 |
27 | Erickson Bruce Kipp Chief Operating Officer |
2022-03-18 21:15:14 | 18,196 0 |
18,196 | Form 4 |
28 | Carillo Carlos N SVP Regulatory Affairs |
2021-10-26 21:53:55 | 17,681 0 |
17,681 | Form 4 |
29 | Ullerich Melissa Vera Chief Communications Officer |
2022-03-18 21:15:35 | 16,405 0 |
16,405 | Form 4 |
30 | Pommer Jerry Lynn Chief Compliance Officer |
2022-03-18 21:15:30 | 15,172 0 |
15,172 | Form 4 |
31 | Martin James Joseph Director |
2021-01-11 16:57:58 | 0 0 |
0 | Form 3 |
32 | Collins Stephen D. Director |
2021-01-11 16:52:55 | 0 0 |
0 | Form 3 |